This deal could be good news and I am quite curious to know how it will turn out.
I am starting to get worried about cash flow control though as in the previous report they indicated an outflow of $266K for Q2 with $132K for R&D and $80K for administration and corporate costs and in turned out to be $76K and $193K for each item respectively.
Hopefully nothing too bad but something to keep an eye on...